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Background: Universal health coverage through the removal of financial and other barriers to access, particularly
for people who are poor, is a global priority. This viewpoint describes the many pathways to catastrophic health
expenditure (CHE) for patients with Acute Coronary Syndrome (ACS) based on two case studies and the thematic
analysis of field notes regarding 210 patients and their households from a study based in Kerala, India.
Discussion: There is evidence of the severe financial impact of non-communicable diseases (NCDs), which is in
contradiction to the widely acclaimed Kerala model: Good health at low cost. However, it is important to look
beyond the out-of-pocket expenditure (OOPE) and CHE to the possible pathways and identify the triggers that
make families vulnerable to CHE. The identified pathways include a primary and secondary loop. The primary
pathway describes the direct path by which families experience CHE. These include: 1) factors related to the pre-
event period that increase the likelihood of experiencing CHE, such as being from the lower socio-economic strata
(SES), past financial losses or loans that leave families with no financial shock absorber at the time of illness; 2)
factors related to the acute event, diagnosis, treatment and hospitalization and expenditures incurred for the same
and; 3) factors related to the post-event period such as loss of gainful employment and means of financing both
the acute period and the long-term management particularly through distress financing. The secondary pathway
arises from the primary and includes: 1) the impact of distress financing and; 2) the long- and short- term
consequences of CHE. These factors ultimately result in a vicious cycle of debt and poverty through non-
compliance and repeat acute events.
Summary: This paper outlines the direct and indirect pathways by which patients with ACS and their families are
trapped in a vicious cycle of debt and poverty. It also contradicts the prevailing impression that only low-income
families are susceptible to CHE, distress financing and their aftermaths and underscores the need for a deeper
understanding at the micro-level, if Kerala and India as a whole are to undertake the difficult exercise of achieving
universal health coverage to successfully tackle its growing NCD burden.
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‘Universal health coverage through removal of financial
and other barriers to access, particularly for people who
are poor, is a priority but political commitment will be
needed’ [1]. This statement from a background paper for
the 2010 Global Symposium on Health System Research
and reiterated in the Lancet article ‘Priority actions for
Non-communicable disease crisis’ [2] embodies both the
critical gap as well as the glaring reality associated with
financial protection in most low- and middle- income
countries (LMICs) including India. While this is true for
any illness, chronic non-communicable diseases (NCDs)
like coronary artery disease (CAD), stroke and diabetes,
with their expensive treatment options (particularly for
acute events), life-long medication and reduced earning
potential, extract a higher toll from patients and their
families [3-5]. In India, NCDs accounted for 53% of all
deaths and 44% of Disability-Adjusted Life-Years in 2005
with the lower socio-economic strata (SES) at higher risk
[6]. Moreover, premature NCD mortality (< 60 years),
which affects the most productive age groups, accounted
for a major portion of total NCD deaths (males – 38%,
females – 32%) [7].
The macro-economic impact of NCDs have been stud-
ied extensively [8,9] but studies detailing their effect at
the micro-level largely rely on national household sur-
veys or are confined to a few diseases in relatively small
settings [3,10]. Furthermore, studies looking at the im-
pact of catastrophic health expenditure (CHE) at this
level are fewer still [11]. This micro-view is important in
order to understand both, where the different strategies
to address CHE should be targeted and how it will affect
the concerned individuals and their families. Hence, the
objective of this paper is to describe the many pathways
to CHE for patients with Acute Coronary Syndrome
(ACS) – the major cause of deaths in CAD. While doing
so, I would like to argue that financial protection, which
includes financial access, is one of the most important
deciding factors in the treatment and management of
acute events related to NCDs.
Discussion
1. Out-of-pocket and catastrophic health expenditure for
ACS
This is a viewpoint arising mainly from analysis of quali-
tative data related to a study on out-of-pocket expend-
iture (OOPE) from 210 cases of ACS in Kerala State.
ACS-related direct and indirect expenditure data were
collected for a nine-month period: three months pre-
event and six months post-event and OOPE was esti-
mated for the same period [12]. In addition to the quan-
titative data, detailed field notes were maintained for
each of the study participants regarding: 1) family cir-
cumstances prior to the illness; 2) coping strategies usedby the family to handle the increased financial burden
and; 3) the problems encountered while accessing health
care, arranging finances and during the follow-up period.
Two case studies were also recorded and transcribed ver-
batim after obtaining appropriate informed consent.
Thematic analysis was done on both the field notes and
the case studies [13]. Emerging descriptive themes were
coded and analyzed within the broad framework of pre-
event, acute event and post-event periods. Themes and
their categories were then interlinked to identify the vari-
ous pathways that lead to CHE as shown in Figure 1.
CHE for the purpose of this study was defined as ACS-
related expenditures exceeding 40% of a household’s an-
nual non-food expenditure [14]. Median ACS-related ex-
penditure was 116,795 INR~ 2,570 USD (Range: 275 –
19,550 USD) and CHE was experienced by as many as
84% of study participants including all socio-economic
strata. [12] Study participants belonging to the low SES
were 15 times more likely to have experienced CHE
compared to their counterparts (odds ratio (OR): 14.51,
95% Confidence Interval (CI): 1.69-124.41). Those whose
jobs were adversely affected were seven times more likely
(OR: 7.21, CI: 1.54-33.80), those who had no health se-
curity were six times more likely (OR: 6.00, CI: 2.02-
17.81) and those who underwent any intervention were
three times more likely to have experienced CHE (OR:
3.24, CI: 1.03-10.16). [12] ACS imposed large financial
burdens on families, with OOPE up to 9 times their total
household expenditures, depending on their socio-
economic status and type of treatment availed. In fact
the magnitude of the OOPE is such that only a small
proportion managed to limit their ACS-related expend-
iture within their overall household expenditure. This
included those from the high SES, those who had some
form of health security coverage for their illness and
those who did not have to resort to distress financing to
meet their treatment expenses.
The high OOPE and CHE are no doubt critical find-
ings that need to be tackled seriously. However, in order
to do that, it is important to identify the triggers that
make families vulnerable to CHE and hasten their transi-
tion from ‘high’ to ‘catastrophic’. Understanding these
pathways is essential if our policies and strategies are to
be targeted effectively.
2. Pathways to CHE
The pathways to CHE arise from varied circumstances
and time points and can be described in terms of a pri-
mary and secondary pathway (Figure 1).
Primary pathway
The primary pathway describes only those sets of cir-
cumstances or factors that directly lead to households
experiencing CHE. It can be predominantly explained in
Figure 1 Pathways to Catastrophic Health Expenditure. This figure describes the primary and secondary pathways by which low-, middle-,
and high-income households experience CHE and get trapped in a vicious cycle of illness, debt and poverty. Households enter this cycle through
their first acute coronary syndrome (ACS) event. The cycle is divided into four segments: 1) illness - treatment: factors that prevent households
from receiving adequate treatment; 2) treatment - distress financing: aspects related to treatment financing particularly with respect to
hospitalization and interventions as well as the adverse effect of the illness on employment, all of which tend to increase non-compliance and
lead to repeat acute events; 3) distress financing - consequences: means of distress financing that increase the intensity and duration of CHE; 4)
consequences – illness: short- and long-term consequences of CHE experienced by households in their journey through the cycle. The events
grouped together in this segment aggravate CHE as the cycle repeats itself, at the same time, households experiencing CHE are at higher risk of
undergoing these consequences leading to prolonged indebtedness and (or) impoverishment (depicted by ⇆).
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the household prior to the illness; employment status of
the patient and household and effect of illness on the
employment; presence or absence of health security;
treatment requirement in terms of hospitalizations and
intervention and; the means of treatment financing and
in particular, the need to resort to distress financing.These have been well documented in India and other
settings as well [11,15-18].
Many families are already vulnerable to CHE when they
become ill: if they are from the lower SES, have no assets
or have incurred financial losses or taken out previous
loans to meet costs for education or marriage of children
or treatment of other family members. This is aggravated
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stantial amount for treatment in a relatively short time.
Only 29% of the study households had some form of
health security coverage (partial or complete) for their
ACS episode(s) while 70% had resorted to loans or asset
sales to finance their treatment of which 50% were first-
time applicants [12]. Acute events like ACS are sudden
and often traumatic, leaving families helpless and desper-
ate. Individuals and families are caught unaware as treat-
ment options are expensive and their savings or assets
are usually insufficient. In the rush to mobilize immedi-
ate funds, they opt for quick solutions, i.e., distress finan-
cing, often from illegitimate sources. Legitimate financial
institutions require time, endless paperwork and the pos-
session of demonstrable assets. On the other hand, the
extensive subculture of local moneylenders who are
known in Kerala slang as ‘Blade’, because of their rather
cut-throat tactics, require no processing time but charge
high daily interest rates. This type of loan does not even
provide temporary respite as interest is accrued daily and
there is constant pressure to repay the interest amount
to keep the loan viable. With regards to employment,
ACS rendered a few individuals incapable of continuing
their jobs; while many employers forced their ill employ-
ees to retire, fearing loss of productivity; which tends to
further push families into a vicious cycle of ill health, dis-
tress financing & poverty.
Secondary pathway
The secondary pathway is a by-product of the primary
pathway and includes the impact of distress financing
and the short- and long-term consequences of CHE.
In a predominantly collectivist culture such as that
found in India including Kerala, the burden of ill-health
tends to be shared among all household members albeit
unequally. While all family members are forced to bear
the brunt of such a misfortune, the more vulnerable
members in the equation, particularly women and chil-
dren, tend to take on the burden disproportionately [19].
Many children discontinued their education and started
working to add to the family income. Many spouses also
started working for the first time in their lives. Families
moved out of expensive rental accommodation to
cheaper or ‘free’ accommodation with obliging relatives
and children were transferred to cheaper schools which
were perceived to offer only sub-standard education.
Households used multiple cost-cutting strategies like
those mentioned above to adjust their expenses even in
the short six-month post-event period. Non-compliance
was another form of ‘adjustment’ which involved choos-
ing a cheaper treatment alternative or forgoing long-
term medications that is the mainstay of any chronic dis-
ease management. Thus, families became further suscep-
tible to the threat of future acute events owing to thelack of treatment or follow-up medication, ultimately
leading to a never-ending vicious cycle. (Figure 1).
In the case of distress financing via local moneylenders,
exploitation was frequent, as property deeds or other
assets that guarantee these transactions were seized when
families were unable to repay. This leads to life-time in-
debtedness in many cases which may even be passed on to
the next generation, particularly among the low SES. They
deplete not just their emergency funds, but also their fu-
ture prospects when children have had to drop out of
school. Many of them also faced the stigma of being la-
beled a ‘charity case’ by exasperated relatives.
In addition, there are other factors which exacerbate
this vicious cycle (Figure 1). The emotional trauma of
having to cope with the illness, the resulting financial
and mental exhaustion, the distress of watching their
families struggle to survive and make ends meet in the
aftermath of the illness and its treatment, the social iso-
lation that results from a fear among relatives that such
an individual may become a burden to them and feeling
of utter helplessness and hopelessness when they foresee
no end to their struggles.
These tangible and intangible pathways to CHE, includ-
ing powerful emotions that cannot be quantified, are best
illustrated by means of the quite contrasting stories of two
men who were diagnosed to have ACS, Mr. Mani and Mr.
Kumar (names changed to ensure confidentiality).
3. CHE: two contrasting perspectives
i. Am I a charity case?
“I am not sure how long I can take my medicines. I
have a credit account with the local pharmacy. They
also help me out with samples from medical
representatives. I cannot be a charity case forever, can
I?” (Quote by Mr. Mani, 50 yrs. ACS patient)
Mr. Mani (50 yrs.) was diagnosed with ACS at a public
hospital and initially refused to undergo an angioplasty
due to lack of financial resources. However, a second epi-
sode within days forced him to undergo the intervention
on an emergency basis. His treatment was financed
solely through ‘Blade’ money which he could not repay
(79,567 INR~1,751 USD). His illness left him unable to
continue his previous work; carrying loads which earned
him an average of INR 775~ 17 USD daily. He could
barely walk without chest pain, but still went to the
‘agarbatti’ (incense stick) rolling factory where he did
supervisory work for 30 INR~ 0.7 USD a day.
“How can I sit at home? Even my daughter, who is still
studying, now gives tuition before she goes for her
classes and my wife has also started working. So, I
have to at least do my share.” “Right now, I am staying
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water or electricity charges. My other sister has cut all
ties with me. She fears that I will become a burden on
her and her family. Can I really blame her?” (Quote
by Mr. Mani, 50 yrs. ACS patient)ii. Could I have managed otherwise?
“I don’t have to pay even a rupee for my medicines.
When the local pharmacist told me that my monthly
medicines cost around INR 3,000, I got a shock. I don’t
know how I would have managed if I had had to pay for
it myself.” (Quote by Mr. Kumar, 66 yrs. ACS patient)
Mr. Kumar (66 yrs.), a retired army man, had been
estranged from his children for a few years. A widower, he
found refuge in an old people’s home in the city following
his wife’s suicide two years ago. His monthly pension of
INR 2,000~ 44 USD is sufficient to manage his day-to-day
life including his room rent and food. When he suddenly
fell ill, he had to undergo an angiogram and angioplasty,
all within the space of five days for which he spent 185,580
INR~4,085 USD. Being a retired government servant
from the armed forces, a category of government employ-
ees who enjoy the best social security benefits in the coun-
try, his treatment was financed directly by the government
office concerned. This also covered his regular follow-up
visits including his monthly medications.
According to Mr. Kumar, managing his daily life simul-
taneously with his illness would have been impossible on
his meager pension alone. Predictably, he has to contend
with bureaucratic hurdles which he describes as a ‘small’
price for the privilege of being stress-free.
No doubt, these two stories represent the extreme ends
of the CHE spectrum. With the highest CAD prevalence
in India (rural - 7.5%, urban – 12%) [20], Kerala has many
such stories that will provide the in-between shades of this
spectrum. But they do not explain the ‘why’, which may be
better answered through some background facts related to
the Kerala health system.4. CHE and the Kerala health system
The high OOPE and CHE have been reported elsewhere
with respect to CVD-related hospitalizations (including
ACS) where India (Kerala) had the highest 15-month
OOPE and more than 80% of the low- and middle- in-
come groups and more than 60% of the high income
group experienced CHE [4]. These figures are also
reflected in the health financing data which shows that
Kerala state has the highest private expenditure (90.3%)
compared to any other state in India [21]. Since the rela-
tionship between OOPE, NCDs and CHE has been long
established [5], these findings are to be expectedconsidering the high prevalence of NCDs and their risk
factors in the state [20,22,23].
This evidence of severe financial impact is perhaps sur-
prising for some as the Kerala health system was once
advocated as the ideal -‘Good Health at Low Cost’ model
[24]. It has however come under considerable pressure
as a result of the combination of low public health
spending and the steep rise in healthcare costs, especially
for NCDs. The lax regulations in establishing private
healthcare institutions, the dramatic rise in disposable
income among the population, their changing expecta-
tions and consumerist attitudes have all contributed to
this deplorable state of affairs [25]. Moreover, as is the
case with the rest of India, primary healthcare is free
only in principle. The poor can theoretically opt for
cheaper or ‘free’ in-patient care through price discrimin-
ation [26]. However, facilities for the treatment of NCDs
and their acute events are few in the public sector and
the available facilities are not completely free even for
the poor. Moreover, critical medicines are often unavail-
able and under-the-table, informal payment practices are
rampant [27,28]. Kerala’s advanced stage of epidemio-
logical transition [22] further compounds the problem
with NCDs like CAD becoming more prevalent, particu-
larly among the poor.
This study highlights some of the possible background
factors pertaining to the Kerala health system that may
have contributed to its failure to protect its citizens from
the financial consequences of seeking treatment. These
factors, namely inadequate budgetary provision for
health [29], lack of preparedness of the public health sys-
tem to face the current and upcoming NCD burden
[30,31] and lack of an effective mechanism to counter
CHE, are interlinked and have been identified both in
India and other settings [32]. The findings of this study
presented here as well as elsewhere [12] demonstrate
that while it is important to provide essential drugs and
the best treatment options, it is far more important to
ensure that these are affordable and accessible to all.
While considering the treatment acquisition process, fi-
nancial access and protection are akin to the basic
physiological needs described in Maslow’s hierarchy of
needs [33]. Once this need is met, other factors will sur-
face, but at present the basic need is paramount.
First, the budgetary provision for health in Kerala state
is grossly inadequate [34]. Consequently, the public ser-
vices are under-funded. With deaths from NCDs pro-
jected to increase substantially in the coming years, the
scale of CHE is likely to spin out of control. While indi-
viduals and households are largely burdened with this
cost of care, the cost to the state machinery will be stag-
gering if nothing is done, as it will also include the loss
of productive man-hours. Health is the responsibility of
the individual state governments in India. Hence, it
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mitment of the Indian government to increase public
spending on health from less than 1% to 3% of Gross
Domestic Product (GDP) [21].
Second, the public health system in Kerala, one of the
most advanced in India, is not geared towards the man-
agement of NCDs and is unable to mitigate the conse-
quences of seeking treatment. The government health
services are less prepared to manage the complications
of NCDs than the for-profit sector. The for-profit health
services have fully capitalized on the government’s inabil-
ity to recognize the growing NCD burden in the state
and filled that gap [35], extracting a disproportionately
high price from all but the very rich. They are over-
endowed with up-to-date technology and have world
class facilities thus resulting in substantial overheads and
ordinarily such centers would be patronized only by the
upper economic classes, i.e., those who can afford it.
However, that is not the case in Kerala as even the poor
are forced to turn to them in the absence of accessible
public health services [26,36]. Unfortunately, this has
come with a price, both literally and figuratively speak-
ing. In other words, Kerala has started to sacrifice the
welfare gains of the past and the market is gradually tak-
ing over the health sector [25]. This needs to be
reversed. The Kerala public health system cannot just sit
back and wait until it is completely sidelined by the for-
profit sector [26,35]. It is time for an overhaul, and a
strengthening of the public health system in Kerala, not
unlike the one that the Lancet authors of the call to ac-
tion “Towards universal health coverage by 2020” have
in mind for the whole of India [37]. The public health
system should be the primary provider of promotive,
preventive, curative and rehabilitative health services, to
improve quality and reduce the OOPE on health care.
Where necessary, the for-profit sector should be regu-
lated and integrated within the health care system [35].
Third, taking into consideration the chronic nature of
NCDs and the various costs incurred by the families, a
viable financing mechanism is warranted to avert CHE.
A part of the solution, as stated above, lies in increasing
the government spending on health. Kerala should give
top priority to financial protection for its citizens on the
health sector agenda. While the new national health in-
surance initiative, called the RSBY-CHIS (Rashtriya
Swasthya Bima Yojna – Comprehensive Health Insu-
rance Scheme) [38] which is currently being implemen-
ted in the state through private insurance providers, is a
step in the right direction, it is unfortunately not
grounded in reality. Neither Kerala’s disease profile with
its distinct leaning towards the NCD end of the
spectrum [20,22,23] nor the historical lessons regarding
serious equity compromises related to private health in-
surance have been given due consideration [39]. TheKerala healthcare stakeholders should be serious in their
efforts to curb OOPE and the increased health sector
funding will have to be paid through pre-payment
schemes or higher taxes.
Admittedly, Kerala is an outlier in India. It is one of the
most educationally forward states in India (including fe-
male literacy) and its major health indicators are compar-
able to the developed Western world. [24] While Kerala
has been a role model for India as well as the whole world
through many of its achievements, in the NCD context, it
is a harbinger of disasters to come unless trends and be-
haviour can be broken or changed. So, while Kerala is cur-
rently not representative of the rest of India, it has
important lessons to learn and to impart to the country as
a whole, as well as to other LMICs through its struggle to
place the growing NCD epidemic and the need for univer-
sal coverage within an appropriate framework.
Health is the basic right of an individual. ‘Health for
All’ is of course what we work towards and hope for, but
‘Healthcare for All’ may be a more attainable goal. As
seen in this study, direct payments at the point of entry
will create serious problems for all but the most wealthy.
Considering the evidence available from around the
globe, universal health coverage is therefore the way to
go [2,40]. It is feasible in various settings, with relatively
limited resources. Countries as diverse as the Czech Re-
public, Slovakia, Rwanda and Thailand [14,22,41,42] are
showing the way. We need to study how and why it
worked there and what we need to do to make it work
for us, taking into account our basic realities as well as
our fundamental differences. It is imperative that Kerala
and India as a whole undertake the difficult challenge of
universal health coverage if it is to successfully tackle its
growing NCD burden.
Summary
This paper looks beyond the evidence of the severe finan-
cial impact of ACS at the micro-level and attempts to map
out the various pathways by which households experience
CHE. The primary pathway describes the direct path by
which families experience CHE. These include: 1) factors
related to the pre-event period that increase the likelihood
of experiencing CHE, such as being from the lower SES,
past financial losses or loans that leave families with no fi-
nancial shock absorber at the time of illness; 2) factors
related to the acute event, diagnosis, treatment and
hospitalization and expenditures incurred for the same
and; 3) factors related to the post-event period such as loss
of gainful employment and means of financing both the
acute period and the long-term management particularly
through distress financing. The secondary pathway arises
from the primary and includes: 1) the impact of distress fi-
nancing and; 2) the long- and short- term consequences of
CHE. These factors ultimately loop back into a vicious
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peat acute events. It further contradicts the prevailing no-
tion that only low-income families are susceptible to CHE,
distress financing and their aftermaths, particularly for
acute events related to NCDs and emphasises the need for
a deeper understanding at the micro-level if we are to ar-
rive at viable solutions that will benefit the vast majority.
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